![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, May 06, 2019 8:36:41 AM
Again, Andy seems to jump the shark every time.
The main reason I think they should have stayed with the dream team is becuse I expect the approval process to become even more difficult now that the FDA knows that he's navigating thru this difficult terrain alone (the FDA can use any excuse because Andy has NO BACK UP), FDA is about to be knee deep in the fight to keep big pharma on top.
They expect this fight because they see how close HEMP/CANNABIS is to becoming recreationally legal, ending the prohibition (people will self medicate because their are less side effects from
H/C). Now dozens of electricueticals about to hit their desk for approvals, things are about to change bigtime for big pharma. Don't worry, the FDA will be right their to prop them up when they get blindsided.
I look at the FDA as the blanky for big pharma. If only Andy had better skills at navigating thru this, obviously he doesn't.
My comments above are simply my opinion and nothing more.
I'm enthusiastic at times however I am NOT a professional trader.
Please contact a financial consultant for investment advice.
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM